New lab model of Alzheimer's disease will help research

February 16, 2012
New lab model of Alzheimer's disease will help research
A confocal image of a brain affected by Alzheimer’s disease, showing a region of amyloid plaque. Credit: Med Mic Sciences Cardiff Uni, Wellcome Images.

(Medical Xpress) -- A new way of studying Alzheimer’s disease in the laboratory has been developed by scientists at the Wellcome Trust and Cancer Research UK Gurdon Institute in Cambridge and will help researchers understand more clearly how the disease progresses in real life.

The researchers took created from skin cells donated by volunteers and used them to generate populations of nerve cells that behave just like the cells in a human brain. This model could be used both to follow how Alzheimer's disease starts and progresses in people and to test and develop potential new treatments for the disease.

Crucially, the cells used were from volunteers with Down's syndrome. People with Down's syndrome are at a higher risk of developing Alzheimer's disease and are often diagnosed with it in middle age; consequently, by using their stem cells, the progression of Alzheimer's disease can be tracked faster than by using cells from the general population. In the lab, the model develops disease over a matter of months rather than the years or decades that it takes in real life.

Animal models have been used effectively for research into Alzheimer's disease, but it is difficult to reproduce every aspect of the disease. Using human cells, the new model develops all the hallmarks of Alzheimer's disease as it appears in patients' brains studied post-mortem: it shows the same plaques of a protein called amyloid, as well as 'tangles' of another protein called tau, and many other characteristic features.

Amyloid is derived from a precursor called APP (amyloid precursor protein), which is controlled by a gene on chromosome 21. People with Down's syndrome have an extra copy of chromosome 21, which is why they are at greater risk of developing Alzheimer's disease and of developing it at an earlier age than other people. This also explains why using stem cells from people with Down's syndrome contributes to the increased rate at which the new model progresses in the lab.

Dr Rick Livesey, who led the study (which was published yesterday in Science Translational Medicine), said: "One of the biggest challenges facing dementia researchers at the moment is a lack of good ways to track the disease over time. By using stem cells donated from people with Down's syndrome, we have been able to track how the disease develops over a shorter time period than has been possible in the past.

"What is promising about this stem cell technique is that we can create functioning human cortex cells in a dish, allowing us to more closely model what is happening in our brains. Not only this, but our new shows many of the characteristic features of human and will allow us to test new treatments more easily."

Explore further: Brain cells created from patients' skin cells

More information: Shi Y et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Trans Med 2012 (epub ahead of print).

Related Stories

Brain cells created from patients' skin cells

February 7, 2012
(Medical Xpress) -- Cambridge scientists have, for the first time, created cerebral cortex cells – those that make up the brain’s grey matter – from a small sample of human skin.  The researchers’ ...

Road block as a new strategy for the treatment of Alzheimer's

August 22, 2011
Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception ...

Alzheimer's protein kills nerve cells in nose

September 27, 2011
A protein linked to Alzheimer's disease kills nerve cells that detect odors, according to an animal study in the September 28 issue of The Journal of Neuroscience. The findings shed light on why people with Alzheimer's disease ...

Study reveals link between high cholesterol and Alzheimer's disease

September 12, 2011
People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

Recommended for you

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

Researchers unlock the molecular origins of Alzheimer's disease

September 6, 2017
A "twist of fate" that is minuscule even on the molecular level may cause the development of Alzheimer's disease, VCU researchers have found.

Is dementia declining among older Americans?

September 5, 2017
(HealthDay)—Here's some good news for America's seniors: The rates of Alzheimer's and other forms of dementia have dropped significantly over the last decade or so, a new study shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.